Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gongjing Yankang Gel is a proprietary Traditional Chinese Medicine (TCM) formulation developed and manufactured by Jiangxi Baishen Changnuo Pharmaceutical Co., Ltd. It is a topical vaginal gel indicated for the treatment of acute and chronic cervicitis, as well as infections caused by *Chlamydia trachomatis*. The preparation is composed of several herbal extracts, including *Sophora flavescens* (Ku Shen), *Cnidium monnieri* (She Chuang Zi), and Borneol (Bing Pian). These active constituents work synergistically to provide antimicrobial, anti-inflammatory, and analgesic effects. The gel is designed to clear heat, dry dampness, and promote the healing of the cervical mucosa, effectively reducing abnormal vaginal discharge and alleviating local inflammation associated with gynecological infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gongjing Yankang Gel.